Please login to the form below
anxiety
This page shows the latest anxiety news and features for those working in and with pharma, biotech and healthcare.
Moderna looks to price COVID-19 vaccine at $50-$60 per course
If finalised, these new executive orders could force us to rethink those plans, consider job reductions and add to the economic and health anxiety already widely felt in our country,” he
Latest news
-
Low-dose LSD looks safe for Alzheimer’s patients, but will it work?
Earlier studies point to potential benefits for LSD in depression, anxiety, and substance abuse, and Eleusis’ hope is that low dose LSD may also have significant potential in treating Alzheimer’s,
-
Karuna’s shares spike on schizophrenia drug data
anxiety, that can seriously limit the clinical effectiveness of current antipsychotic drugs, most of which have been in use for decades.
-
Prescription drug dependence 'linked to deprivation', says PHE
This included benzodiazepines for anxiety and insomnia, z-drugs for insomnia, gapapentinoids for neuropathic pain, opioid pain medications for chronic non-cancer pain and antidepressants.
-
Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment
Pear Therapeutics says the study also showed improvements in anxiety symptoms (as measured by the General Anxiety Disorder 7-item (GAD-7) scale), with a treatment arm mean of 3.16
-
Otsuka’s Alzheimer’s agitation drug hits the mark
antipsychotic drugs – which have been linked to a higher risk of death in dementia – as well as antidepressants and anxiety medications.
Low-dose LSD looks safe for Alzheimer’s patients, but will it work?
Karuna’s shares spike on schizophrenia drug data
Prescription drug dependence 'linked to deprivation', says PHE
Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment
Otsuka’s Alzheimer’s agitation drug hits the mark
More from news
Approximately 1 fully matching, plus 149 partially matching documents found.
Latest Intelligence
-
New thinking, bold action: building a better future for people living with severe diseases
to doctors and medicines, and understandably heightened levels of uncertainty, anxiety and stress.
-
Helping patients to help themselves – how pharma can get more from patient support programmes
For example, the Sanvello app () uses cognitive behavioural therapy to help patients relieve stress, anxiety and depression.
-
2021: the year of decentralisation in drug development
Moreover, deploying healthcare professionals who are trained to carry out a wide range of services and tests in the patient’s home can reduce anxiety, and increase comfort and convenience, while
-
Not waving but drowning – reflections on data curation in the age of information overload
Adding in all the other information that comes our way over the course of a 24-hour period, is it any surprise that terms like ‘information anxiety’, ‘infobesity’ and even ‘infoxication’
-
Health trust in a COVID-19 world – a unique opportunity for pharma
a whole has become a more valuable commodity as uncertainty and anxiety around COVID-19 and its impact has become more prevalent.
New thinking, bold action: building a better future for people living with severe diseases
Helping patients to help themselves – how pharma can get more from patient support programmes
2021: the year of decentralisation in drug development
Not waving but drowning – reflections on data curation in the age of information overload
Health trust in a COVID-19 world – a unique opportunity for pharma
More from intelligence
Approximately 0 fully matching, plus 25 partially matching documents found.
Latest appointments
-
Dr Niall Murphy and Pierre Schwich join Pharnext
Prior to this, Dr Murphy served as a unit leader for a team of scientists collaborating on research in the areas of addition biology, Alzheimer's disease, anxiety, depression and neurotoxicity
-
Turing names Eliseo Salinas as head of R&D
Salinas has played a leading role in numerous programmes for a range of diseases and disorders, with specific focus on central nervous systems (CNS) condition such as depression and anxiety, schizophrenia,
Dr Niall Murphy and Pierre Schwich join Pharnext
Turing names Eliseo Salinas as head of R&D
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Employee wellbeing in creative agencies: three tips to get you started
Research suggests that living in this state creates chronic stress contributing to high blood pressure, formation of artery-clogging deposits and brain changes that may contribute to anxiety, depression and addiction.
-
'Smear Word' campaign for Roche aims to break taboos and save lives
if we addressed anxieties, uncovered what actually takes place at appointments and raise the importance of this screening.”.
-
Supporting Mental Health During a Global Pandemic
Sam Duboc, Chair &CEO of MindBeacon, explores virtual care and telehealth for treating depression, anxiety, addiction, and other conditions; mental health issues brought on by COVID-19; and how to virtually
-
6 reasons patients drop out of clinical trials and 6 ways to fix it
Understandably, patients can go through a rollercoaster of emotions throughout a trial — fear, stress, anxiety, and more.
-
Feeling the pressure?
you’ve been able to successfully thrive on and embrace suddenly generates anxiety. To some extent that tipping point depends on the environment and culture of the company you work in, ... 2. Three quarters cited comms agencies as the most stressful
6 reasons patients drop out of clinical trials and 6 ways to fix it
More from PMHub
Approximately 2 fully matching, plus 48 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Digital project manager
-
Competitive
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
-
Digital account director
-
Competitive
-
Digital strategist
-
Competitive
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
-
Events Executive
-
Depending on Experience
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- bluebird bio to restart marketing of Zynteglo in EU after previous suspension
- Live Webinar: Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- Another Landmark Lucid Workiversary
- Amgen pays $900m upfront to acquire Teneobio’s antibody assets, R&D technologies
- Biogen and Eisai present new data for controversial Alzheimer's drug Aduhelm at AAIC
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
No results were found
PMHub
The Good Ideas Group
Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
